Precision medicine, often known as personalized medicine, is becoming an important aspect of current cancer treatment. It involves adapting treatment to mutations detected in the patient's tumor rather than tailoring treatment to a person's individual genome sequence. Precision medicine in cancer entails analyzing DNA from tumors to find mutations or other genetic abnormalities that cause the cancer. Healthcare professionals may therefore be able to choose a treatment for a specific patient's cancer that best fits, or targets, the tumor DNA alterations. Such treatments are becoming more prominent. Precision medicine already has a significant impact on cancer diagnosis and therapy, and it will become even more so in the future.
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece